🇺🇸 FDA
Patent

US 11376263

Cyproterone acetate compositions and uses thereof

granted A61KA61K31/567A61K31/573

Quick answer

US patent 11376263 (Cyproterone acetate compositions and uses thereof) held by Fortress Biotech, Inc. expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fortress Biotech, Inc.
Grant date
Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/567, A61K31/573, A61K9/0053, A61K9/20